We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 5,956 results
  1. Resource Agent Map** of Healthcare and Pharmaceutical Systems

    Healthcare and pharmaceutical markets are composed of multiple interdependent resources and agents who adapt their behaviours in response to one...
    Rossen Kazakov, Penka Petrova, Yavora Kazakova in Understanding and Managing Socioeconomic Systems Behaviour
    Chapter 2024
  2. Research on the Effectiveness of Clarifying Rumors by Listed Companies in the Pharmaceutical Industry – Taking the Market Reaction of Ling Pharmaceutical as an Example

    The stock market is the information market, and issuing clarification announcements is an important way for listed companies to respond to rumors and...
    Conference paper 2024
  3. The Chinese Healthcare and Pharmaceutical Market: Ignore at Your Own Peril

    China’s healthcare industry is one of the largest sectors of GDP for the country. The Chinese healthcare market is the second biggest globally. The...
    Sven Agten, Ben Wu in Biopharma in China
    Chapter 2024
  4. Partnership Models for R &D in the Pharmaceutical Industry

    Over the last decades the complexity of R &D processes in the pharmaceutical industry have resulted in a decline in the efficiency of those...
    Gianpaolo Iazzolino, Rita Bozzo in Quantitative Models in Life Science Business
    Chapter Open access 2023
  5. What Factors are Driving R&D in the Pharmaceutical Industry in India? A Study of the Post-Liberalization Period

    There exist a significant number of studies to find the fundamental factors driving R&D in the Indian pharmaceutical industry. Firm size, firm age,...

    Aruna Pain, Indrani Chakraborty in Journal of Quantitative Economics
    Article 12 June 2023
  6. A Profile of the Indian Pharmaceutical Companies

    Before going to the detailed discussion of Indian pharmaceutical companies’ profile, it’s better to have a crystal clear idea pertain to the...
    Chapter 2022
  7. Configurational Analysis of ESG Performance, Innovation Intensity, and Financial Leverage: a Study on Total Factor Productivity in Chinese Pharmaceutical Manufacturing Firms

    Environmental, social, and governance (ESG) performance has emerged as a critical aspect of responsible investing, garnering global attention within...

    Juan Tan, **yu Wei in Journal of the Knowledge Economy
    Article 08 December 2023
  8. Location of the Largest Pharmaceutical Companies in Russia: Contribution to Regional Divergence or Convergence?

    Abstract—

    The objective of the article is to identify factors for the location of pharmaceutical enterprises in Russian regions, including from the...

    O. V. Kuznetsova, R. O. Bobrovsky in Regional Research of Russia
    Article 01 June 2022
  9. Pharmaceutical markets in Japan and the United States

    Although the United States and Japan are the two largest markets for branded pharmaceuticals, their structures and market performance are quite...

    Article Open access 09 August 2022
  10. Marketing Activities of Indian Pharmaceutical Companies

    Marketing always starts with the customer and ends with the customer as they are the valuable assets for any country, and all marketers are very much...
    Chapter 2022
  11. Evolving market boundaries and competition policy enforcement in the pharmaceutical industry

    Competition investigations start with market definition, which establishes the perimeter of the competitive analysis. In this paper, we focus on the...

    Georges Siotis, Carmine Ornaghi, Micael Castanheira in European Journal of Law and Economics
    Article Open access 09 February 2023
  12. An in-Depth Exploration of the Evolution and Implementation of Halal Pharmaceutical Certification Schemes in Malaysia

    Malaysia is a leader in halal pharmaceutical certification. With the global demand for halal pharmaceuticals on the rise, this study aims to shed...
    Johari Ab Latiff, Zalina Zakaria, Sa’adan Man in Islamic Finance
    Chapter 2024
  13. Orthopedics SMEs and Pharmaceutical Giants in Switzerland

    Switzerland is a small, open economy, and its medtech industry is one of the most integrated in the existing global networks. An examination of M&A...
    Pierre-Yves Donzé in Medtech
    Chapter 2022
  14. New evidence on the health and employment effects of non-pharmaceutical COVID-19 interventions on workers in the United States

    We provide new evidence on the economic and health impacts of government- mandated non-pharmaceutical interventions (NPIs) during the COVID-19...

    Ege Aksu, Prabal K. De, Laxman Timilsina in Empirical Economics
    Article 26 June 2024
  15. Research and Development (R&D) Activities of the Indian Pharmaceutical Companies

    In pharmaceutical industry, R&D can be considered as any activity to resolve scientific uncertainty and unknown targeted at accomplishing an advance...
    Chapter 2022
  16. The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996–2019

    We analyze the association that pharmaceutical innovation had with premature mortality from all diseases in Switzerland during the period 1996–2018,...

    Article Open access 14 March 2022
  17. Does FDI Induce Knowledge Spillovers? Evidence from Indian Pharmaceutical Industry

    The study examines knowledge spillovers from multinational firms in the pharmaceutical industry in India. Specifically, we examine if FDI catalyses...
    Ramesh Jangili, N. R. V. V. M. K. Rajendra Kumar, N. Srinivasa Rao in Studies in International Economics and Finance
    Chapter 2022
  18. Non-pharmaceutical Interventions and COVID-19: Do County- and State-Level Policies Predict the Spread of COVID-19?

    This study examines the impact of county- and state-level policies on the spread and severity of COVID-19 in communities in the USA during the first...

    Amanda C. Stype, Mehmet E. Yaya, Jayson Osika in Journal of Economics, Race, and Policy
    Article 15 February 2023
  19. On the Mechanisms of Pharmaceutical Pollution of the Environment Risk Reduction

    Purpose The purpose of the study is to determine the main mechanisms and measures to reduce the level of environmental risks due to the widespread...
    Vladimir S. Belov, Natalia V. Ivanova, Alexander I. Samarkin in Industry 4.0
    Chapter 2022
  20. Introduction to Pharmaceutical Marketing Management

    The terminologyPharmaceutical marketing ‘Market’ has been obtained from a Latin word: ‘marcatus’ which denotes a place where business or commercial...
    Chapter 2022
Did you find what you were looking for? Share feedback.